Lipolysis and apoptosis of adipocytes induced by neuropeptide Y-Y5 receptor antisense oligodeoxynucleotides in obese rats

Acta Pharmacologica Sinica

Volumn 24, Issue 6, 2003, Pages 569-575+622

  Gong, Hai Xia ^a   Guo, Xi Rong ^a   Fei, Li ^a   Guo, Mei ^a   Liu, Qian Qi ^a   Chen, Rong Hua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Adipocytes; Apoptosis; Bax genes; Bcl 2 genes; Lipolysis; Neuropeptide Y; Neuropeptide Y receptors; Obesity

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DNA FRAGMENT; DRUG VEHICLE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y3 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; PROTEIN BAX; PROTEIN BCL 2;

ADIPOCYTE; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BAX GENE; BCL 2 GENE; BODY WEIGHT; CALCULATION; DRUG EFFECT; ELECTROPHORESIS; GENE; GENE EXPRESSION; LIPOLYSIS; MALE; NONHUMAN; OBESITY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BODY WEIGHT; DNA FRAGMENTATION; LIPOLYSIS; MALE; OBESITY; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; RNA, MESSENGER;

EID: 0038170402     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999; 20: 68-100.
2. Yanovski JA, Yanovski SZ. Recent advances in basic obesity research. JAMA 1999; 282: 1504-6.
3. Balasubramaniam AA. Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides 1997; 18: 445-57.
4. Criscione L, Rigollier P, Batzl-Hartmann C, Rueger H, Stricker-Krongrad A, Wyss P, et al. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor. J Clin Invest 1998; 102: 2136-45.
5. Schaffhauser AO, Stricker-Krongrad A, Brunner L, Cumin F, Gerald C, Whitebread S, et al. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes 1997; 46: 1792-8.
6. Tang-Christensen M, Kristensen P, Stidsen CE, Brand CL, Larsen PJ. Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y. J Endocrinol 1998; 159: 307-12.
7. Flynn MC, Turrin NP, Plata-Salaman CR, Ffrench-Mullen JM. Feeding response to neuropeptide Y-related compounds in rats treated with Y5 receptor antisense or sense phosphothio-oligodeoxynucleotide. Physiol Behav 1999; 66: 881-4.
8. Margareto J, Aguado M, Oses-Prieto JA, Rivero I, Monge A, Aldana I, et al. A new NPY-antagonist strongly stimulates apoptosis and lipolysis on white adipocytes in an obesity model. Life Sci 2000; 68: 99-107.
9. Briscini L, Tonello C, Dioni L, Carruba MO, Nisoli E. Bcl-2 and Bax: are involved in the sympathetic protection of brown adipocytes from obesity-linked apoptosis. FEBS Lett 1998; 431: 80-4.
10. Qian BC. The principle and methods prepare obesity model. Chin Pharmacol Bull 1993; 9: 75-6.
11. Gaudette MF, Crain WR. A simple method for quantifying specific mRNA in small number of early mouse embryos. Nucl Acid Res 1991; 19: 1879-84.
12. Blomqvist AG, Herzog H. Y-receptor subtypes - how many more? Trends Neurosci 1997; 20: 294-8.
13. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl- Hartmann C, Smith KE, et al. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 1996; 382: 168-71.
14. Wyss P, Stricker-Krongrad A, Brunner L, Miller J, Crossthwaite A, Whitebread S, et al. The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes. Regul Pept 1998; 75-76: 363-71.
15. Levine AS, Billington CJ. Why do we eat? A neural systems approach. Annu Rev Nutr 1997; 17: 597-619.
16. Billington CJ, Briggs JE, Harker S, Grace M, Levine AS. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol 1994; 266 (6 Pt 2): R1765-70.
17. Horton TJ, Hill JO. Prolonged fasting significantly changes nutrient oxidation and glucose tolerance after a normal mixed meal. J Appl Physiol 2001; 90: 155-63.
18. Etherton TD. The biology of somatotropin in adipose tissue growth and nutrient partitioning. J Nutr 2000; 130: 2623-5.
19. Berk PD, Zhou S, Kiang C, Stump DD, Fan X, Bradbury MW. Selective up-regulation of fatty acid uptake by adipocytes characterizes both genetic and diet-induced obesity in rodents. J Biol Chem 1999; 274: 28626-31.
20. Eckel RH, Jensen DR, Schlaepfer IR, Yost TJ. Tissue-specific regulation of lipoprotein lipase by isoproterenol in normal-weight humans. Am J Physiol 1996; 271 (5 Pt 2): R1280-6.
21. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev 1998; 78: 783-809.
22. Kohgo Y, Kato J. Role of apoptosis on morphogenesis and therapy in malignancy. Intern Med 1998; 37: 182-4.
23. Qian H, Hausman GJ, Compton MM, Azain MJ, Hartzell DL, Baile CA. Leptin regulation of peroxisome proliferator-activated receptor-gamma, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissues. Biochem Biophys Res Commun 1998; 246: 660-7.
24. Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, et al. Troglitazone increased the number of small adipocyte without change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998; 101: 1354-61.